↓ Skip to main content

A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma

Overview of attention for article published in Investigational New Drugs, October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
4 X users
googleplus
1 Google+ user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
16 Mendeley
Title
A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma
Published in
Investigational New Drugs, October 2018
DOI 10.1007/s10637-018-0678-6
Pubmed ID
Authors

Y. Cai, Fei Wang, Q. Liu, Z. Li, D. Li, Z. Sun

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 19%
Student > Master 2 13%
Student > Postgraduate 2 13%
Student > Ph. D. Student 1 6%
Researcher 1 6%
Other 1 6%
Unknown 6 38%
Readers by discipline Count As %
Medicine and Dentistry 7 44%
Biochemistry, Genetics and Molecular Biology 1 6%
Immunology and Microbiology 1 6%
Computer Science 1 6%
Unknown 6 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2020.
All research outputs
#13,455,122
of 23,884,161 outputs
Outputs from Investigational New Drugs
#712
of 1,222 outputs
Outputs of similar age
#164,149
of 353,114 outputs
Outputs of similar age from Investigational New Drugs
#8
of 15 outputs
Altmetric has tracked 23,884,161 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,222 research outputs from this source. They receive a mean Attention Score of 4.9. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,114 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.